Matches in Nanopublications for { ?s ?p "[KRAS mutations were infrequently identified in gallbladder carcinoma (2/29, 7%) and high-grade dysplastic lesions (0/5, 0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP453290.RAiQfqy5yiMXm3fzI1JntFuyk9t4og3cM3d7RK8qpV0F0130_assertion description "[KRAS mutations were infrequently identified in gallbladder carcinoma (2/29, 7%) and high-grade dysplastic lesions (0/5, 0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP453290.RAiQfqy5yiMXm3fzI1JntFuyk9t4og3cM3d7RK8qpV0F0130_provenance.
- NP871277.RAcH4r9Gc9AYTCMd-9SFNaLrB915Lj8w3rZsJOktuR-p4130_assertion description "[KRAS mutations were infrequently identified in gallbladder carcinoma (2/29, 7%) and high-grade dysplastic lesions (0/5, 0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP871277.RAcH4r9Gc9AYTCMd-9SFNaLrB915Lj8w3rZsJOktuR-p4130_provenance.
- NP527625.RAAivPe_cxWqmYDnvTiH5VEfxnzzBm8dkvrlZTyYOfynQ130_assertion description "[KRAS mutations were infrequently identified in gallbladder carcinoma (2/29, 7%) and high-grade dysplastic lesions (0/5, 0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP527625.RAAivPe_cxWqmYDnvTiH5VEfxnzzBm8dkvrlZTyYOfynQ130_provenance.